COVID-19

The novel coronavirus (COVID-19) vaccinations producer by Pfizer/BioNTech and Moderna likely produce an immune response that is strong and

Epstein-Barr virus (EBV) reactivation resulting from the inflammatory response to novel coronavirus (COVID-19) infection may be the cause of

The novel coronavirus (COVID-19) variant B.1.617.2, also known as the Delta variant, could be dominant in the United States in a few weeks, according

Novel coronavirus (COVID-19) therapies made from combinations of two antibodies are effective against a wide range of variants of the virus,

SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19), may have the ability to reactivate dormant tuberculosis (TB), and infection with

Stress, anxiety, and depression during the first few weeks of the novel coronavirus (COVID-19) pandemic were associated with less and lower quality

Exposure to natural spaces during the first novel coronavirus (COVID-19) lockdown in 2020 was beneficial for mental health, according to a new study

Researchers at the University of Maryland School of Medicine (UMSOM) have developed two rapid diagnostic tests for the novel coronavirus (COVID-19)